Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...
Why Eli Lilly Stock Topped the Market Today
Eli Lilly (NYSE: LLY) stock was the picture of health on Friday. Shares of the massive American pharmaceutical company rose ...
Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.
Eli Lilly started 2024 on a strong note but struggled during the second half of the year. The drugmaker dealt with several ...
MM&M23h
Novo Nordisk’s amycretin cuts weight by 22% in early obesity trial
The Danish pharma giant posted impressive data for amycretin one month after the disappointing readout of CagriSema.
MarketWatch21h
Brent Crude Oil Continuous Contract
2-Year U.S. Treasury Note Continuous Contract $102.727 0.000 0.00% 5-Year U.S. Treasury Note Continuous Contract $106.063-0.008-0.01% 10-Year U.S. Treasury Note Continuous Contract $108.359-0.016 ...